The University of Chicago Header Logo

Connection

Dejan Micic to Humans

Back to Details
This is a "connection" page, showing publications Dejan Micic has written about Humans.
Dejan Micic
Connection Strength
1.049
Humans
  1. Revisiting the Risk of Hospital Readmission in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2024 Apr 03; 30(4):688-689.
    View in: PubMed
    Score: 0.032
  2. Outcomes of parenteral nutrition in patients with advanced cancer and malignant bowel obstruction. Support Care Cancer. 2024 Mar 04; 32(3):206.
    View in: PubMed
    Score: 0.032
  3. Predictive Model for Positive Video Capsule Endoscopy in Iron Deficiency Anemia. Dig Dis Sci. 2023 07; 68(7):3083-3091.
    View in: PubMed
    Score: 0.030
  4. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients. Viruses. 2022 08 19; 14(8).
    View in: PubMed
    Score: 0.029
  5. Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative Colitis. Dig Dis Sci. 2023 03; 68(3):897-901.
    View in: PubMed
    Score: 0.029
  6. Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis. J Hematol Oncol. 2022 02 05; 15(1):15.
    View in: PubMed
    Score: 0.028
  7. Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2021 10 18; 27(10):1620-1625.
    View in: PubMed
    Score: 0.027
  8. Bariatric Bypass Surgery Is a Risk Factor for Incomplete Colonoscopy Preparation. Dig Dis Sci. 2022 07; 67(7):3185-3191.
    View in: PubMed
    Score: 0.027
  9. Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis. Gastroenterology. 2022 Jan; 162(1):88-108.e9.
    View in: PubMed
    Score: 0.027
  10. Impact of Early Video Capsule Endoscopy on Hospitalization and Post-hospitalization Outcomes: A Propensity Score-Matching Analysis. Dig Dis Sci. 2022 08; 67(8):3584-3591.
    View in: PubMed
    Score: 0.027
  11. Evaluation of the fibrosis-4 index for detection of advanced fibrosis among individuals at risk for intestinal failure-associated liver disease. JPEN J Parenter Enteral Nutr. 2022 03; 46(3):678-684.
    View in: PubMed
    Score: 0.027
  12. Nutrition Considerations in Inflammatory Bowel Disease. Nutr Clin Pract. 2021 Apr; 36(2):298-311.
    View in: PubMed
    Score: 0.026
  13. Role of Video Capsule Endoscopy as a Prelude to Deep Enteroscopy. Gastrointest Endosc Clin N Am. 2021 Apr; 31(2):331-344.
    View in: PubMed
    Score: 0.026
  14. Nutrition Support in the ICU-A Refresher in the Era of COVID-19. Am J Gastroenterol. 2020 09; 115(9):1367-1370.
    View in: PubMed
    Score: 0.025
  15. Long-Term Outcomes With Teduglutide From a Single Center. JPEN J Parenter Enteral Nutr. 2021 02; 45(2):318-322.
    View in: PubMed
    Score: 0.025
  16. Hiding in the Water. N Engl J Med. 2020 May 07; 382(19):1844-1849.
    View in: PubMed
    Score: 0.025
  17. Role of Diet in the Development and Management of Crohn's Disease. Curr Gastroenterol Rep. 2020 Mar 17; 22(4):19.
    View in: PubMed
    Score: 0.024
  18. Evaluation of Fibrosis in Intestinal Failure-Associated Liver Disease in the Sustain Registry. JPEN J Parenter Enteral Nutr. 2020 09; 44(7):1285-1290.
    View in: PubMed
    Score: 0.024
  19. Risk Stratification of Angioectasia as a Cause of Gastrointestinal Bleeding: Untangling the Spider's Web? Dig Dis Sci. 2019 10; 64(10):2693-2695.
    View in: PubMed
    Score: 0.024
  20. Getting to the Root of the Problem. Gastroenterology. 2020 04; 158(5):1229-1231.
    View in: PubMed
    Score: 0.024
  21. Celiac Disease and Its Role in the Development of Metabolic Bone Disease. J Clin Densitom. 2020 Apr - Jun; 23(2):190-199.
    View in: PubMed
    Score: 0.023
  22. Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy. PLoS One. 2019; 14(2):e0212509.
    View in: PubMed
    Score: 0.023
  23. Risk of Cancer Recurrence Among Individuals Exposed to Antitumor Necrosis Factor Therapy: A Systematic Review and Meta-Analysis of Observational Studies. J Clin Gastroenterol. 2019 01; 53(1):e1-e11.
    View in: PubMed
    Score: 0.022
  24. Choosing the Right Central Venous Catheter for Parenteral Nutrition. Am J Gastroenterol. 2019 01; 114(1):4-6.
    View in: PubMed
    Score: 0.022
  25. Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 04; 63(4):1016-1024.
    View in: PubMed
    Score: 0.021
  26. How to Obtain Training in Nutrition During the Gastroenterology Fellowship. Gastroenterology. 2018 Feb; 154(3):467-470.
    View in: PubMed
    Score: 0.021
  27. Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One. 2017; 12(8):e0182900.
    View in: PubMed
    Score: 0.020
  28. Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors' reply. Aliment Pharmacol Ther. 2017 05; 45(10):1372.
    View in: PubMed
    Score: 0.020
  29. Mediastinal granuloma: a rare cause of dysphagia. BMJ Case Rep. 2016 Jun 14; 2016.
    View in: PubMed
    Score: 0.019
  30. Describing the clinical phenotypes of Crohn's disease: lessons from the past: commentary on: the broadening conception of regional ileitis. Dig Dis Sci. 2014 Jan; 59(1):6-8.
    View in: PubMed
    Score: 0.016
  31. Older Age at First Screening Colonoscopy is Associated With an Increased Risk of Colorectal Adenomas and Cancer. J Clin Gastroenterol. 2023 09 01; 57(8):804-809.
    View in: PubMed
    Score: 0.008
  32. Readmission and Disposition in Patients With Malignant Bowel Obstructions Following Gastrostomy Tube. Am Surg. 2023 Dec; 89(12):5915-5920.
    View in: PubMed
    Score: 0.008
  33. Factors associated with poor compliance amongst hospitalized, predominantly adolescent pediatric Crohn's disease patients. Ann Med. 2022 12; 54(1):886-892.
    View in: PubMed
    Score: 0.007
  34. Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes. Dig Dis Sci. 2023 04; 68(4):1464-1472.
    View in: PubMed
    Score: 0.007
  35. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems. Clin Infect Dis. 2022 06 10; 74(11):2028-2035.
    View in: PubMed
    Score: 0.007
  36. Review article: drug-induced small bowel injury. Aliment Pharmacol Ther. 2021 12; 54(11-12):1370-1388.
    View in: PubMed
    Score: 0.007
  37. Risk of Colorectal Cancer in Serrated Polyposis Syndrome: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022 03; 20(3):622-630.e7.
    View in: PubMed
    Score: 0.007
  38. Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without HIPEC. Ann Surg Oncol. 2021 Nov; 28(12):6955-6964.
    View in: PubMed
    Score: 0.007
  39. The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn's Disease. Digestion. 2021; 102(5):767-775.
    View in: PubMed
    Score: 0.006
  40. Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Lee. Ann Rheum Dis. 2023 04; 82(4):e84.
    View in: PubMed
    Score: 0.006
  41. Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Yang et al. Ann Rheum Dis. 2023 04; 82(4):e80.
    View in: PubMed
    Score: 0.006
  42. Efficacy and Safety of Monoclonal Antibodies Against Clostridioides difficile Toxins for Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2021 01; 55(1):43-51.
    View in: PubMed
    Score: 0.006
  43. Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study. Clin Gastroenterol Hepatol. 2022 02; 20(2):381-389.e9.
    View in: PubMed
    Score: 0.006
  44. Response to 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Gremese et al. Ann Rheum Dis. 2023 01; 82(1):e6.
    View in: PubMed
    Score: 0.006
  45. Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes. Clin Gastroenterol Hepatol. 2021 11; 19(11):2444-2446.e2.
    View in: PubMed
    Score: 0.006
  46. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2021 03; 80(3):384-391.
    View in: PubMed
    Score: 0.006
  47. Risk of Cancers in Patients with Pediatric Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. J Pediatr. 2021 02; 229:102-117.e36.
    View in: PubMed
    Score: 0.006
  48. The risk of respiratory tract infections and interstitial lung disease with interleukin 12/23 and interleukin 23 antagonists in patients with autoimmune diseases: A systematic review and meta-analysis. J Am Acad Dermatol. 2021 Mar; 84(3):676-690.
    View in: PubMed
    Score: 0.006
  49. Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis. Int J Colorectal Dis. 2020 Nov; 35(11):2113-2116.
    View in: PubMed
    Score: 0.006
  50. Drug-Induced Colitis. Clin Gastroenterol Hepatol. 2021 09; 19(9):1759-1779.
    View in: PubMed
    Score: 0.006
  51. TGR5 signaling mitigates parenteral nutrition-associated liver disease. Am J Physiol Gastrointest Liver Physiol. 2020 02 01; 318(2):G322-G335.
    View in: PubMed
    Score: 0.006
  52. Medical Management of Opioid-Induced Constipation. JAMA. 2019 12 10; 322(22):2241-2242.
    View in: PubMed
    Score: 0.006
  53. Systematic review with meta-analysis: risk of new onset IBD with the use of anti-interleukin-17 agents. Aliment Pharmacol Ther. 2019 08; 50(4):373-385.
    View in: PubMed
    Score: 0.006
  54. Risk of Fractures in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2019 07; 53(6):441-448.
    View in: PubMed
    Score: 0.006
  55. Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095.
    View in: PubMed
    Score: 0.006
  56. Risk Factors for 30-day Hospital Readmission for Diverticular Hemorrhage. J Clin Gastroenterol. 2019 04; 53(4):e133-e141.
    View in: PubMed
    Score: 0.006
  57. Risk of Colorectal Cancer in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2018 10; 52(9):796-804.
    View in: PubMed
    Score: 0.006
  58. Gastrointestinal cancers in patients with cystic fibrosis - Authors' reply. Lancet Oncol. 2018 08; 19(8):e369.
    View in: PubMed
    Score: 0.005
  59. Gastrointestinal cancer risk in cystic fibrosis: more exploration is needed - Authors' reply. Lancet Oncol. 2018 07; 19(7):e333.
    View in: PubMed
    Score: 0.005
  60. Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 02; 17(3):486-493.
    View in: PubMed
    Score: 0.005
  61. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol. 2018 06; 19(6):758-767.
    View in: PubMed
    Score: 0.005
  62. Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860.
    View in: PubMed
    Score: 0.005
  63. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.
    View in: PubMed
    Score: 0.005
  64. Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Clin Pharmacol Ther. 2018 02; 103(2):318-331.
    View in: PubMed
    Score: 0.005
  65. Autoimmune gastrointestinal dysmotility due to small cell lung cancer. BMJ Case Rep. 2017 Aug 11; 2017.
    View in: PubMed
    Score: 0.005
  66. Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis. J Gastroenterol Hepatol. 2017 Jun; 32(6):1143-1151.
    View in: PubMed
    Score: 0.005
  67. Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-a agent (infliximab), in inflammatory bowel diseases. Aliment Pharmacol Ther. 2017 04; 45(8):1043-1057.
    View in: PubMed
    Score: 0.005
  68. Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis. Gastrointest Endosc. 2017 Jul; 86(1):93-104.e5.
    View in: PubMed
    Score: 0.005
  69. Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-a use in females with immune mediated diseases; a systematic review and meta-analysis. J Autoimmun. 2017 01; 76:38-52.
    View in: PubMed
    Score: 0.005
  70. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. J Crohns Colitis. 2016 Dec; 10(12):1385-1394.
    View in: PubMed
    Score: 0.005
  71. Primary Care Evaluation and Management of Gastroenterologic Issues in Women. Obstet Gynecol Clin North Am. 2016 Jun; 43(2):347-66.
    View in: PubMed
    Score: 0.005
  72. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016 May; 31(5):1025-30.
    View in: PubMed
    Score: 0.005
  73. Hematochezia and a Mesenteric Mass. Gastroenterology. 2015 Jul; 149(1):e12-3.
    View in: PubMed
    Score: 0.004
  74. Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015 Jul 15; 61(2):233-41.
    View in: PubMed
    Score: 0.004
  75. Patchy colitis and interstitial lung disease. Gastroenterology. 2015 Jan; 148(1):26-7.
    View in: PubMed
    Score: 0.004
  76. In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease. J Crohns Colitis. 2014 Nov; 8(11):1539-47.
    View in: PubMed
    Score: 0.004
  77. Challenges in the diagnosis of Clostridium difficile infection. Gastroenterology. 2014 Jun; 146(7):1820-2.
    View in: PubMed
    Score: 0.004
  78. The systemic inflammatory response to Clostridium difficile infection. PLoS One. 2014; 9(3):e92578.
    View in: PubMed
    Score: 0.004
  79. Storage duration of red blood cell transfusion and Clostridium difficile infection: a within person comparison. PLoS One. 2014; 9(2):e89332.
    View in: PubMed
    Score: 0.004
  80. Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adults. J Am Geriatr Soc. 2013 Oct; 61(10):1738-42.
    View in: PubMed
    Score: 0.004
  81. Understanding increased mortality in Clostridium difficile-infected older adults. Clin Infect Dis. 2013 Aug; 57(4):625-6.
    View in: PubMed
    Score: 0.004
  82. Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS One. 2013; 8(3):e58265.
    View in: PubMed
    Score: 0.004
  83. Reply to Walker et al. Clin Infect Dis. 2013 Jun; 56(12):1846-7.
    View in: PubMed
    Score: 0.004
  84. Reply to McDonald. Clin Infect Dis. 2013 Mar; 56(6):907-8.
    View in: PubMed
    Score: 0.004
  85. Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis. 2012 Dec; 55(12):1661-8.
    View in: PubMed
    Score: 0.004
  86. [Diverticulosis of the digestive tract in our patients over a 10-year period]. Zb Vojnomed Akad. 1981; 23:42-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.